The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Large Volume Parenteral (LVP) Market Research Report 2024

Global Large Volume Parenteral (LVP) Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1415847

No of Pages : 97

Ask Your Query

Synopsis

Large volume parenterals or LVPs (sometimes called large volume injections) are aqueous solutions usually supplied in volumes of at least 100 ml with sizes of 250 ml, 500 ml, 1000 ml, 3000 ml, and 5000 ml most common. Directions usually recommend that large quantities be administered. Parenteral preparations are sterile, solid dosage form or pyrogen-free liquids, which contain one or more number of active ingredients boxed in single or multi dose containers. They are meant to be administered either by infusion, transplantation or injection in the body. Parenteral formulations are classified into small and large based on their volume. Small volume parenteral formulations are 100ml or more and can be given as single or multi dose, whereas large volume parenteral preparations are more than 100ml, intended for single use.

The global Large Volume Parenteral (LVP) market was valued at US$ 10530 million in 2023 and is anticipated to reach US$ 14000 million by 2030, witnessing a CAGR of 4.1% during the forecast period 2024-2030.

The main Large Volume Parenteral (LVP) players include Baxter Healthcare, Kelun Pharma, B. Braun, Fresenius, Teva Pharmaceutical Industries, etc. The top five Large Volume Parenteral (LVP) players account for approximately 66% of the total global market. Asia-Pacific is the largest consumer market for Large Volume Parenteral (LVP) accounting for about 47%, followed by Europe and North America. In terms of Type, Soft Bag LVP is the largest segment, with a share about 56%. And in terms of Application, the largest application is Therapeutic Infusion, followed by Basic Infusion.

This report aims to provide a comprehensive presentation of the global market for Large Volume Parenteral (LVP), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Large Volume Parenteral (LVP).

Report Scope

The Large Volume Parenteral (LVP) market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Large Volume Parenteral (LVP) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Large Volume Parenteral (LVP) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • Baxter Healthcare
  • Kelun Pharma
  • B. Braun
  • Fresenius
  • Teva Pharmaceutical Industries
  • Pfizer (Hospira)
  • Ostuka Pharmaceutical
  • CR Double-Crane
  • Pisa
  • Huaren
  • Patheon
  • Beximco Pharma
  • Albert David
  • PSI Ltd
  • Ozon Pharmaceuticals
  • BAG Healthcare
  • BML Parenteral Drugs

Segment by Type

  • Soft Bag LVP
  • Plastic Bottle LVP
  • Glass Bottle LVP

Segment by Application

  • Basic Infusion
  • Therapeutic Infusion
  • Nutritious Infusion

Consumption by Region

  • North America (United States, Canada and Mexico)
  • Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
  • South America (Brazil, Argentina, Colombia, and Rest of South America)
  • Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Large Volume Parenteral (LVP) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Large Volume Parenteral (LVP) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Index

1 Large Volume Parenteral (LVP) Market Overview
1.1 Product Overview and Scope of Large Volume Parenteral (LVP)
1.2 Large Volume Parenteral (LVP) Segment by Type
1.2.1 Global Large Volume Parenteral (LVP) Market Value Comparison by Type (2024-2030)
1.2.2 Soft Bag LVP
1.2.3 Plastic Bottle LVP
1.2.4 Glass Bottle LVP
1.3 Large Volume Parenteral (LVP) Segment by Application
1.3.1 Global Large Volume Parenteral (LVP) Market Value by Application: (2024-2030)
1.3.2 Basic Infusion
1.3.3 Therapeutic Infusion
1.3.4 Nutritious Infusion
1.4 Global Large Volume Parenteral (LVP) Market Size Estimates and Forecasts
1.4.1 Global Large Volume Parenteral (LVP) Revenue 2019-2030
1.4.2 Global Large Volume Parenteral (LVP) Sales 2019-2030
1.4.3 Global Large Volume Parenteral (LVP) Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Large Volume Parenteral (LVP) Market Competition by Manufacturers
2.1 Global Large Volume Parenteral (LVP) Sales Market Share by Manufacturers (2019-2024)
2.2 Global Large Volume Parenteral (LVP) Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Large Volume Parenteral (LVP) Average Price by Manufacturers (2019-2024)
2.4 Global Large Volume Parenteral (LVP) Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Large Volume Parenteral (LVP), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Large Volume Parenteral (LVP), Product Type & Application
2.7 Large Volume Parenteral (LVP) Market Competitive Situation and Trends
2.7.1 Large Volume Parenteral (LVP) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Large Volume Parenteral (LVP) Players Market Share by Revenue
2.7.3 Global Large Volume Parenteral (LVP) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Large Volume Parenteral (LVP) Retrospective Market Scenario by Region
3.1 Global Large Volume Parenteral (LVP) Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Large Volume Parenteral (LVP) Global Large Volume Parenteral (LVP) Sales by Region: 2019-2030
3.2.1 Global Large Volume Parenteral (LVP) Sales by Region: 2019-2024
3.2.2 Global Large Volume Parenteral (LVP) Sales by Region: 2025-2030
3.3 Global Large Volume Parenteral (LVP) Global Large Volume Parenteral (LVP) Revenue by Region: 2019-2030
3.3.1 Global Large Volume Parenteral (LVP) Revenue by Region: 2019-2024
3.3.2 Global Large Volume Parenteral (LVP) Revenue by Region: 2025-2030
3.4 North America Large Volume Parenteral (LVP) Market Facts & Figures by Country
3.4.1 North America Large Volume Parenteral (LVP) Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Large Volume Parenteral (LVP) Sales by Country (2019-2030)
3.4.3 North America Large Volume Parenteral (LVP) Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Large Volume Parenteral (LVP) Market Facts & Figures by Country
3.5.1 Europe Large Volume Parenteral (LVP) Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Large Volume Parenteral (LVP) Sales by Country (2019-2030)
3.5.3 Europe Large Volume Parenteral (LVP) Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Large Volume Parenteral (LVP) Market Facts & Figures by Country
3.6.1 Asia Pacific Large Volume Parenteral (LVP) Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Large Volume Parenteral (LVP) Sales by Country (2019-2030)
3.6.3 Asia Pacific Large Volume Parenteral (LVP) Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Large Volume Parenteral (LVP) Market Facts & Figures by Country
3.7.1 Latin America Large Volume Parenteral (LVP) Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Large Volume Parenteral (LVP) Sales by Country (2019-2030)
3.7.3 Latin America Large Volume Parenteral (LVP) Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Large Volume Parenteral (LVP) Market Facts & Figures by Country
3.8.1 Middle East and Africa Large Volume Parenteral (LVP) Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Large Volume Parenteral (LVP) Sales by Country (2019-2030)
3.8.3 Middle East and Africa Large Volume Parenteral (LVP) Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Large Volume Parenteral (LVP) Sales by Type (2019-2030)
4.1.1 Global Large Volume Parenteral (LVP) Sales by Type (2019-2024)
4.1.2 Global Large Volume Parenteral (LVP) Sales by Type (2025-2030)
4.1.3 Global Large Volume Parenteral (LVP) Sales Market Share by Type (2019-2030)
4.2 Global Large Volume Parenteral (LVP) Revenue by Type (2019-2030)
4.2.1 Global Large Volume Parenteral (LVP) Revenue by Type (2019-2024)
4.2.2 Global Large Volume Parenteral (LVP) Revenue by Type (2025-2030)
4.2.3 Global Large Volume Parenteral (LVP) Revenue Market Share by Type (2019-2030)
4.3 Global Large Volume Parenteral (LVP) Price by Type (2019-2030)
5 Segment by Application
5.1 Global Large Volume Parenteral (LVP) Sales by Application (2019-2030)
5.1.1 Global Large Volume Parenteral (LVP) Sales by Application (2019-2024)
5.1.2 Global Large Volume Parenteral (LVP) Sales by Application (2025-2030)
5.1.3 Global Large Volume Parenteral (LVP) Sales Market Share by Application (2019-2030)
5.2 Global Large Volume Parenteral (LVP) Revenue by Application (2019-2030)
5.2.1 Global Large Volume Parenteral (LVP) Revenue by Application (2019-2024)
5.2.2 Global Large Volume Parenteral (LVP) Revenue by Application (2025-2030)
5.2.3 Global Large Volume Parenteral (LVP) Revenue Market Share by Application (2019-2030)
5.3 Global Large Volume Parenteral (LVP) Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Baxter Healthcare
6.1.1 Baxter Healthcare Corporation Information
6.1.2 Baxter Healthcare Description and Business Overview
6.1.3 Baxter Healthcare Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Baxter Healthcare Large Volume Parenteral (LVP) Product Portfolio
6.1.5 Baxter Healthcare Recent Developments/Updates
6.2 Kelun Pharma
6.2.1 Kelun Pharma Corporation Information
6.2.2 Kelun Pharma Description and Business Overview
6.2.3 Kelun Pharma Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Kelun Pharma Large Volume Parenteral (LVP) Product Portfolio
6.2.5 Kelun Pharma Recent Developments/Updates
6.3 B. Braun
6.3.1 B. Braun Corporation Information
6.3.2 B. Braun Description and Business Overview
6.3.3 B. Braun Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 B. Braun Large Volume Parenteral (LVP) Product Portfolio
6.3.5 B. Braun Recent Developments/Updates
6.4 Fresenius
6.4.1 Fresenius Corporation Information
6.4.2 Fresenius Description and Business Overview
6.4.3 Fresenius Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Fresenius Large Volume Parenteral (LVP) Product Portfolio
6.4.5 Fresenius Recent Developments/Updates
6.5 Teva Pharmaceutical Industries
6.5.1 Teva Pharmaceutical Industries Corporation Information
6.5.2 Teva Pharmaceutical Industries Description and Business Overview
6.5.3 Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Product Portfolio
6.5.5 Teva Pharmaceutical Industries Recent Developments/Updates
6.6 Pfizer (Hospira)
6.6.1 Pfizer (Hospira) Corporation Information
6.6.2 Pfizer (Hospira) Description and Business Overview
6.6.3 Pfizer (Hospira) Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Pfizer (Hospira) Large Volume Parenteral (LVP) Product Portfolio
6.6.5 Pfizer (Hospira) Recent Developments/Updates
6.7 Ostuka Pharmaceutical
6.6.1 Ostuka Pharmaceutical Corporation Information
6.6.2 Ostuka Pharmaceutical Description and Business Overview
6.6.3 Ostuka Pharmaceutical Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Ostuka Pharmaceutical Large Volume Parenteral (LVP) Product Portfolio
6.7.5 Ostuka Pharmaceutical Recent Developments/Updates
6.8 CR Double-Crane
6.8.1 CR Double-Crane Corporation Information
6.8.2 CR Double-Crane Description and Business Overview
6.8.3 CR Double-Crane Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2019-2024)
6.8.4 CR Double-Crane Large Volume Parenteral (LVP) Product Portfolio
6.8.5 CR Double-Crane Recent Developments/Updates
6.9 Pisa
6.9.1 Pisa Corporation Information
6.9.2 Pisa Description and Business Overview
6.9.3 Pisa Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Pisa Large Volume Parenteral (LVP) Product Portfolio
6.9.5 Pisa Recent Developments/Updates
6.10 Huaren
6.10.1 Huaren Corporation Information
6.10.2 Huaren Description and Business Overview
6.10.3 Huaren Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Huaren Large Volume Parenteral (LVP) Product Portfolio
6.10.5 Huaren Recent Developments/Updates
6.11 Patheon
6.11.1 Patheon Corporation Information
6.11.2 Patheon Large Volume Parenteral (LVP) Description and Business Overview
6.11.3 Patheon Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Patheon Large Volume Parenteral (LVP) Product Portfolio
6.11.5 Patheon Recent Developments/Updates
6.12 Beximco Pharma
6.12.1 Beximco Pharma Corporation Information
6.12.2 Beximco Pharma Large Volume Parenteral (LVP) Description and Business Overview
6.12.3 Beximco Pharma Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Beximco Pharma Large Volume Parenteral (LVP) Product Portfolio
6.12.5 Beximco Pharma Recent Developments/Updates
6.13 Albert David
6.13.1 Albert David Corporation Information
6.13.2 Albert David Large Volume Parenteral (LVP) Description and Business Overview
6.13.3 Albert David Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Albert David Large Volume Parenteral (LVP) Product Portfolio
6.13.5 Albert David Recent Developments/Updates
6.14 PSI Ltd
6.14.1 PSI Ltd Corporation Information
6.14.2 PSI Ltd Large Volume Parenteral (LVP) Description and Business Overview
6.14.3 PSI Ltd Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2019-2024)
6.14.4 PSI Ltd Large Volume Parenteral (LVP) Product Portfolio
6.14.5 PSI Ltd Recent Developments/Updates
6.15 Ozon Pharmaceuticals
6.15.1 Ozon Pharmaceuticals Corporation Information
6.15.2 Ozon Pharmaceuticals Large Volume Parenteral (LVP) Description and Business Overview
6.15.3 Ozon Pharmaceuticals Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Ozon Pharmaceuticals Large Volume Parenteral (LVP) Product Portfolio
6.15.5 Ozon Pharmaceuticals Recent Developments/Updates
6.16 BAG Healthcare
6.16.1 BAG Healthcare Corporation Information
6.16.2 BAG Healthcare Large Volume Parenteral (LVP) Description and Business Overview
6.16.3 BAG Healthcare Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2019-2024)
6.16.4 BAG Healthcare Large Volume Parenteral (LVP) Product Portfolio
6.16.5 BAG Healthcare Recent Developments/Updates
6.17 BML Parenteral Drugs
6.17.1 BML Parenteral Drugs Corporation Information
6.17.2 BML Parenteral Drugs Large Volume Parenteral (LVP) Description and Business Overview
6.17.3 BML Parenteral Drugs Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2019-2024)
6.17.4 BML Parenteral Drugs Large Volume Parenteral (LVP) Product Portfolio
6.17.5 BML Parenteral Drugs Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Large Volume Parenteral (LVP) Industry Chain Analysis
7.2 Large Volume Parenteral (LVP) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Large Volume Parenteral (LVP) Production Mode & Process
7.4 Large Volume Parenteral (LVP) Sales and Marketing
7.4.1 Large Volume Parenteral (LVP) Sales Channels
7.4.2 Large Volume Parenteral (LVP) Distributors
7.5 Large Volume Parenteral (LVP) Customers
8 Large Volume Parenteral (LVP) Market Dynamics
8.1 Large Volume Parenteral (LVP) Industry Trends
8.2 Large Volume Parenteral (LVP) Market Drivers
8.3 Large Volume Parenteral (LVP) Market Challenges
8.4 Large Volume Parenteral (LVP) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock